Works matching DE "MITOXANTRONE"

Results: 322

Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, n. 3, p. 252, doi. 10.1111/vco.12092

By:

Tran, C. M.;
Moore, A. S.;
Frimberger, A. E.

Publication type:

Article

Dynamic and Assembly Characteristics of Deep‐Cavity Basket Acting as a Host for Inclusion Complexation of Mitoxantrone in Biotic and Abiotic Systems.

Published in:

Chemistry - A European Journal, 2023, v. 29, n. 68, p. 1, doi. 10.1002/chem.202303374

By:

Pavlović, Radoslav Z.;
Finnegan, Tyler J.;
Metlushko, Anna;
Hansen, Alexandar L.;
Waudby, Christopher A.;
Wang, Xiuze;
Hoefer, Nicole;
McComb, David W.;
Pavić, Aleksandar;
Plackić, Nikola;
Novaković, Jovana;
Bradić, Jovana;
Jeremić, Nevena;
Jakovljević, Vladimir;
Šmit, Biljana;
Matić, Sanja;
Alvarez‐Saavedra, Matias A.;
Čapo, Ivan;
Moore, Curtis E.;
Stupp, Samuel I.

Publication type:

Article

Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1399, doi. 10.1007/s00228-024-03711-8

By:

Xu, Gaoqi;
Yang, Dihong;
Ding, Haiying;
Zhong, Like;
Zhu, Junfeng;
Mi, Xiufang;
Zhang, Xueyuan;
Wu, Zhufeng;
Xin, Wenxiu;
Li, Chunlei;
Wang, Jiaqi;
Fang, Luo

Publication type:

Article

Cumulative Mitoxantrone-Induced Haematological and Hepatic Adverse Effects in a Subchronic In vivo Study.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2014, v. 114, n. 3, p. 254, doi. 10.1111/bcpt.12143

By:

Rossato, Luciana G.;
Costa, Vera M.;
Dallegrave, Eliane;
Arbo, Marcelo;
Dinis‐Oliveira, Ricardo J.;
Santos‐Silva, Alice;
Duarte, José A.;
Lourdes Bastos, Maria;
Palmeira, Carlos;
Remião, Fernando

Publication type:

Article

Application of electric cell-substrate impedance sensing toward personalized anti-cancer therapeutic selection.

Published in:

Journal of Analytical Science & Technology, 2018, v. 9, n. 1, p. 1, doi. 10.1186/s40543-018-0149-x

By:

Adcock, Audrey F.;
Agbai, Chiagozie O.;
Yang, Liju

Publication type:

Article

Efficacy of the CV‑MED regimen in treating extramedullary involvement of multiple myeloma: A case report.

Published in:

2024

By:

Gao, Jinjie;
Dong, Fei;
Zhang, Xu;
Jing, Hongmei

Publication type:

Case Study

Mitoxantrone induces apoptosis in osteosarcoma cells through regulation of the Akt/FOXO3 pathway.

Published in:

Oncology Letters, 2018, v. 15, n. 6, p. 9687, doi. 10.3892/ol.2018.8547

By:

Park, See-Hyoung;
Lee, Jongsung;
Kang, Mi-Ae;
Jang, Kyu Yun;
Kim, Jung Ryul

Publication type:

Article

Ectopic expression of the WWOX gene suppresses stemness of human ovarian cancer stem cells.

Published in:

Oncology Letters, 2015, v. 9, n. 4, p. 1614, doi. 10.3892/ol.2015.2971

By:

HONG CHAO YAN;
JUN XU;
LI SHA FANG;
YING YING QIU;
XIAO MAN LIN;
HONG XIANG HUANG;
QIU YU HAN

Publication type:

Article

Salvage therapy with mitoxantrone, etoposide, bleomycin and dexamethasone for refractory or relapsed aggressive non-Hodgkin's lymphoma patients with a poor performance status or comorbidity.

Published in:

Oncology Letters, 2014, v. 8, n. 5, p. 2012, doi. 10.3892/ol.2014.2517

By:

XUEDE LIN;
XI SHI;
WUCHA ZENG;
MIN ZHENG;
LIMING HUANG

Publication type:

Article

Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 4, p. 488, doi. 10.1038/bmt.2011.109

By:

Waterman, J;
Rybicki, L;
Bolwell, B;
Copelan, E;
Pohlman, B;
Sweetenham, J;
Dean, R;
Sobecks, R;
Andresen, S;
Kalaycio, M

Publication type:

Article

Summarizing Patient Preferences for the Competitive Landscape of Multiple Sclerosis Treatment Options.

Published in:

Medical Decision Making, 2020, v. 40, n. 2, p. 198, doi. 10.1177/0272989X19897944

By:

Jonker, Marcel F.;
Donkers, Bas;
Goossens, Lucas M.A.;
Hoefman, Renske J.;
Jabbarian, Lea J.;
de Bekker-Grob, Esther W.;
Versteegh, Matthijs M.;
Harty, Gerard;
Wong, Schiffon L.

Publication type:

Article

Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options.

Published in:

Drugs, 2019, v. 79, n. 2, p. 125, doi. 10.1007/s40265-018-1039-7

By:

Collongues, Nicolas;
Ayme-Dietrich, Estelle;
Monassier, Laurent;
de Seze, Jérôme

Publication type:

Article

The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis.

Published in:

Drugs, 2017, v. 77, n. 3, p. 303, doi. 10.1007/s40265-017-0692-6

By:

Heath, Gregory;
Airody, Archana;
Gale, Richard

Publication type:

Article

Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors**.

Published in:

Molecular Informatics, 2024, v. 43, n. 3, p. 1, doi. 10.1002/minf.202300284

By:

Ali, Waseem;
Jamal, Salma;
Gangwar, Rishabh;
Ahmed, Faraz;
Sharma, Rahul;
Agarwal, Meetu;
Sheikh, Javaid Ahmad;
Grover, Abhinav;
Grover, Sonam

Publication type:

Article

MOSR and NDH A Genes Comprising G-Quadruplex as Promising Therapeutic Targets against Mycobacterium tuberculosis : Molecular Recognition by Mitoxantrone Suppresses Replication and Gene Regulation.

Published in:

Genes, 2023, v. 14, n. 5, p. 978, doi. 10.3390/genes14050978

By:

Dey, Arpita;
Anand, Kushi;
Singh, Amit;
Prasad, Ramasare;
Barthwal, Ritu

Publication type:

Article

Early Mitoxantrone-Induced Cardiotoxicity Detected in Secondary Progressive Multiple Sclerosis.

Published in:

Clinical Medicine Insights: Therapeutics, 2011, n. 3, p. 449, doi. 10.4137/CMT.S7586

By:

Namaka, M. P.;
Turcotte, D. A.;
Klowak, M.;
Leong, C. M.;
Grossberndt, A.;
Le Dorze, J-A.;
Prout, M. E.;
Andresen, S.;
Vuong, L.;
Melanson, M. J.;
Frost, E. E.;
Doupe, M.

Publication type:

Article

Evolution of treatment of childhood AML: the AML-BFM experience.

Published in:

Pediatric Reports, 2013, v. 5, p. 51

By:

Creutzig, U.

Publication type:

Article

Anthracycline antibiotics derivate mitoxantrone—Destructive sorption and photocatalytic degradation.

Published in:

PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193116

By:

Štenglová-Netíková, Irena R.;
Petruželka, Luboš;
Šťastný, Martin;
Štengl, Václav

Publication type:

Article

Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study.

Published in:

Journal of Research in Medical Sciences, 2012, v. 17, n. 9, p. 828

By:

Tabrizi, Nasim;
Etemadifar, Masoud;
Ashtari, Fereshteh;
Zahed, Arash;
Etemadifar, Fatemeh

Publication type:

Article

Safety and Efficacy of Mitoxantrone Hydrochloride Injection for Identification of Axillary Sentinel Lymph Nodes in Patients with Primary Breast Cancer.

Published in:

World Journal of Surgery, 2023, v. 47, n. 8, p. 1956, doi. 10.1007/s00268-023-07011-7

By:

Elzayat, Ibrahim;
Abdelaal, Mohamed;
Monib, Sherif

Publication type:

Article

A diperiodatoargentate(III)-based chemiluminescence determination of mitoxantrone in pharmaceutical preparations and human serum.

Published in:

2021

By:

Xue, Lili;
Zhang, Min;
Li, Guanghui;
Cao, Jianhua;
Yao, Hanchun

Publication type:

Letter

Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting.

Published in:

Cancer Cell International, 2012, v. 12, n. 1, p. 38, doi. 10.1186/1475-2867-12-38

By:

Jiangning Zhao;
Zhenshu Xu;
Delong Liu;
Quanyi Lu

Publication type:

Article

PRELIMINARY RESULTS OF A PHASE 2 STUDY OF CHIDAMIDE, GEMCITABINE, VINORELBINE, AND MITOXANTRONE LIPOSOME (CHI‐GVM) IN RELAPSED/REFRATORY PERIPHERAL T‐CELL LYMPHOMA.

Published in:

Hematological Oncology, 2023, v. 41, p. 770, doi. 10.1002/hon.3165_617

By:

Yin, H.;
Shen, H.;
Liang, J.;
Wu, J.;
Li, Y.;
Wang, L.;
Li, J.;
Xu, W.

Publication type:

Article

PRELIMINARY RESULTS OF GEMCITABINE, ETOPOSIDE, MITOXANTRONE HYDROCHLORIDE LIPOSOME AND DEXAMETHASONE REGIMEN FOR NEWLY DIAGNOSED EARLY NUAT OR ADVANCED STAGE ENKTL.

Published in:

Hematological Oncology, 2023, v. 41, p. 767, doi. 10.1002/hon.3165_614

By:

Liang, J.;
Shen, H.;
Yin, H.;
Wu, J.;
Li, Y.;
Wang, L.;
Li, J.;
Xu, W.

Publication type:

Article

Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients.

Published in:

2015

By:

Zinzani, Pier Luigi;
Pellegrini, Cinzia;
Broccoli, Alessandro;
Gandolfi, Letizia;
Stefoni, Vittorio;
Casadei, Beatrice;
Maglie, Roberto;
Argnani, Lisa;
Pileri, Stefano

Publication type:

journal article

Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma.

Published in:

Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 9, p. 1689, doi. 10.1007/s00432-015-1963-9

By:

Herold, Michael;
Scholz, Christian;
Rothmann, Frank;
Hirt, Carsten;
Lakner, Volker;
Naumann, Ralph

Publication type:

Article

Résistance au docétaxel: mécanismes et applications thérapeutiques.

Published in:

Oncologie (Tech Science Press), 2012, v. 14, n. 2, p. 113, doi. 10.1007/s10269-012-2122-4

By:

Oudard, S.;
Combe, P.

Publication type:

Article

Isolation and Characterization of a Murine P388 Leukemia Line Resistant to Thiarabine.

Published in:

Nucleosides, Nucleotides & Nucleic Acids, 2012, v. 31, n. 1, p. 14, doi. 10.1080/15257770.2011.637099

By:

Waud, WilliamR.;
Parker, WilliamB.;
Gilbert, KarenS.;
Secrist III, JohnA.

Publication type:

Article

MULTI-WALL CARBON NANOTUBE-BASED DNA NANOSENSOR FOR DETERMINING MITOXANTRONE-DNA INTERACTION IN-VITRO.

Published in:

Instrumentation Science & Technology, 2013, v. 41, n. 3, p. 325, doi. 10.1080/10739149.2012.731459

By:

Lad, AmitkumarN.;
Agrawal, Y.K.

Publication type:

Article

Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report.

Published in:

Malaysian Journal of Pathology, 2016, v. 38, n. 3, p. 315

By:

TANG Yee-Loong;
CHIA Wai-Kit;
Sze-Wai, YAP Ernie Cornelius;
Mohc Idris, JULIA;
LEONG Chooi-Fun;
SALWATI Shuib;
WONG Chieh-Lee

Publication type:

Article

Improved anticancer efficiency of Mitoxantrone by Curcumin loaded PLGA nanoparticles targeted with AS1411 aptamer.

Published in:

Nanomedicine Journal, 2021, v. 8, n. 1, p. 21, doi. 10.22038/nmj.2021.08.03

By:

Hashemi, Maryam;
Haghgoo, Zahra;
Yazdian-Robati, Rezvan;
Shahgordi, Sanaz;
Salmasi, Zahra;
Abnous, Khalil

Publication type:

Article

Theoretical study of functionalized single-walled carbon nanotube (5, 5) with Mitoxantrone drug.

Published in:

Nanomedicine Journal, 2016, v. 3, n. 2, p. 115, doi. 10.7508/nmj.2016.02.005

By:

Shojaie, F.;
Dehghan, M.

Publication type:

Article

Inhibition of DNA Topoisomerase Type IIα (TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study.

Published in:

BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/6817502

By:

Abu Saleh, Md.;
Solayman, Md.;
Hoque, Mohammad Mazharol;
Khan, Mohammad A. K.;
Sarwar, Mohammed G.;
Halim, Mohammad A.

Publication type:

Article

Interceptor potential of C60 fullerene aqueous solution: a comparative analysis using the example of the antitumor antibiotic mitoxantrone.

Published in:

European Biophysics Journal, 2022, v. 51, n. 3, p. 297, doi. 10.1007/s00249-022-01597-x

By:

Salo, Victoria A.;
Buchelnikov, Anatoly S.;
Evstigneev, Maxim P.

Publication type:

Article

Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?

Published in:

CNS Drugs, 2013, v. 27, n. 6, p. 403, doi. 10.1007/s40263-013-0065-y

By:

Edan, Gilles;
Page, Emmanuelle

Publication type:

Article

Mitoxantrone: a review of its use in multiple sclerosis.

Published in:

2004

By:

Scott, Lesley J.;
Figgitt, David P.

Publication type:

journal article

Rituximab Plus Dose-Reduced Cyclophosphamide, Mitoxantrone, Vincristine, and Prednisolone Are Effective in Elderly Patients with Diffuse Large B-Cell Lymphoma of the Thyroid.

Published in:

Thyroid, 2010, v. 20, n. 4, p. 425, doi. 10.1089/thy.2009.0440

By:

Jonak, Constanze;
Troch, Marlene;
Müllauer, Leonhard;
Niederle, Bruno;
Hoffmann, Martha;
Raderer, Markus

Publication type:

Article

Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia.

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29039-4

By:

Anderson, Rebecca;
Miller, Lance D.;
Isom, Scott;
Chou, Jeff W.;
Pladna, Kristin M.;
Schramm, Nathaniel J.;
Ellis, Leslie R.;
Howard, Dianna S.;
Bhave, Rupali R.;
Manuel, Megan;
Dralle, Sarah;
Lyerly, Susan;
Powell, Bayard L.;
Pardee, Timothy S.

Publication type:

Article

New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.

Published in:

Journal of Central Nervous System Disease, 2012, v. 4, n. 3, p. 1, doi. 10.4137/JCNSD.S6692

By:

Nicholas, J.;
Morgan-Followell, B.;
Pitt, D.;
Racke, M.K.;
Boster, A.

Publication type:

Article

Thermostability of the Mitoxantrone - DNA Complexes Irradiated by Non-Thermal Millimeter Electromagnetic Waves.

Published in:

Armenian Journal of Physics, 2016, v. 9, n. 2, p. 173

By:

Karapetyan, A. T.;
Babayan, Yu. S.;
Torosyan, M. A.;
Shahinyan, M. A.

Publication type:

Article

Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.

Published in:

Nanotoxicology, 2016, v. 10, n. 5, p. 557, doi. 10.3109/17435390.2015.1095364

By:

Cicha, Iwona;
Scheffler, Laura;
Ebenau, Astrid;
Lyer, Stefan;
Alexiou, Christoph;
Goppelt-Struebe, Margarete

Publication type:

Article

Vitamin C Effect on Mitoxantrone-Induced Cytotoxicity in Human Breast Cancer Cell Lines.

Published in:

PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0115287

By:

Guerriero, Eliana;
Sorice, Angela;
Capone, Francesca;
Napolitano, Virginia;
Colonna, Giovanni;
Storti, Gabriella;
Castello, Giuseppe;
Costantini, Susan

Publication type:

Article

Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia – Prospective Open Cohort Analyses of the ALLR3 Trial.

Published in:

PLoS ONE, 2014, v. 9, n. 10, p. 1, doi. 10.1371/journal.pone.0108107

By:

Masurekar, Ashish Narayan;
Parker, Catriona A.;
Shanyinde, Milensu;
Moorman, Anthony V.;
Hancock, Jeremy P.;
Sutton, Rosemary;
Ancliff, Philip J.;
Morgan, Mary;
Goulden, Nicholas J.;
Fraser, Chris;
Hoogerbrugge, Peter M.;
Revesz, Tamas;
Darbyshire, Philip J.;
Krishnan, Shekhar;
Love, Sharon B.;
Saha, Vaskar

Publication type:

Article

Inhibition of c-Abl Kinase Activity Renders Cancer Cells Highly Sensitive to Mitoxantrone.

Published in:

PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0105526

By:

Alpay, Kemal;
Farshchian, Mehdi;
Tuomela, Johanna;
Sandholm, Jouko;
Aittokallio, Kaappo;
Siljamäki, Elina;
Kallio, Marko;
Kähäri, Veli-Matti;
Hietanen, Sakari

Publication type:

Article

Therapeutic Options in Docetaxel-Refractory Metastatic Castration-Resistant Prostate Cancer: A Cost-Effectiveness Analysis

Published in:

PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064275

By:

Zhong, Lixian;
Pon, Vickie;
Srinivas, Sandy;
Nguyen, Nicole;
Frear, Meghan;
Kwon, Sherry;
Gong, Cynthia;
Malmstrom, Robert;
Wilson, Leslie

Publication type:

Article

In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine Glioma.

Published in:

PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061512

By:

Veringa, Susanna J. E.;
Biesmans, Dennis;
van Vuurden, Dannis G.;
Jansen, Marc H. A.;
Wedekind, Laurine E.;
Horsman, Ilona;
Wesseling, Pieter;
Vandertop, William Peter;
Noske, David P.;
Kaspers, GertJan J. L.;
Hulleman, Esther

Publication type:

Article

A Subtype-Specific Critical Period for Neurogenesis in the Postnatal Development of Mouse Olfactory Glomeruli.

Published in:

PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048431

By:

Yasuko Kato;
Naoko Kaneko;
Masato Sawada;
Keishi Ito;
Sousuke Arakawa;
Shingo Murakami;
Kazunobu Sawamoto

Publication type:

Article

Pharmacokinetic Properties of 2nd-Generation Fibroblast Growth Factor-1 Mutants for Therapeutic Application.

Published in:

PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0048210

By:

Xue Xia;
Babcock, Joseph P.;
Blaber, Sachiko I.;
Harper, Kathleen M.;
Blaber, Michael

Publication type:

Article

Risk Factors for Metastatic Castration-Resistant Prostate Cancer (CRPC) Predict Long-Term Treatment with Docetaxel.

Published in:

PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0048186

By:

Kawahara, Takashi;
Miyoshi, Yasuhide;
Sekiguchi, Zenkichi;
Sano, Futoshi;
Hayashi, Narihiko;
Teranishi, Jun-ichi;
Misaki, Hiroshi;
Noguchi, Kazumi;
Kubota, Yoshinobu;
Uemura, Hiroji

Publication type:

Article

Adenovirus-Mediated Sensitization to the Cytotoxic Drugs Docetaxel and Mitoxantrone Is Dependent on Regulatory Domains in the E1ACR1 Gene-Region.

Published in:

PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0046617

By:

Miranda, Enrique;
Pineda, Hector Maya;
Öberg, Daniel;
Cherubini, Gioia;
Garate, Zita;
Lemoine, Nick R.;
Halldén, Gunnel

Publication type:

Article